Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

[View FULLTEXT]  
 
Year : 1989  |  Volume : 35  |  Issue : 1  |  Page : 3-8  

Centbutindole vs trifluoperazine : a double-blind controlled clinical study in acute schizophrenia.

DR Doongaji1, RS Satoskar2, AS Sheth3, JS Apte4, AB Desai5, BR Shah6 
1 
2 
3 
4 
5 
6 

Correspondence Address:
D R Doongaji


Twenty-nine acute schizophrenic patients were treated under double-blind conditions for six weeks with either centbutindole in a dose range of 3 mg/day to 4.5 mg/day or trifluoperazine in the dose range of 15 mg/day to 22.5 mg/day. Both drugs produced a significant improvement in initial psychopathology. No significant differences were demonstrated between the two treatment conditions.


How to cite this article:
Doongaji D R, Satoskar R S, Sheth A S, Apte J S, Desai A B, Shah B R. Centbutindole vs trifluoperazine : a double-blind controlled clinical study in acute schizophrenia. J Postgrad Med 1989;35:3-8


How to cite this URL:
Doongaji D R, Satoskar R S, Sheth A S, Apte J S, Desai A B, Shah B R. Centbutindole vs trifluoperazine : a double-blind controlled clinical study in acute schizophrenia. J Postgrad Med [serial online] 1989 [cited 2020 Mar 29 ];35:3-8
Available from: http://www.jpgmonline.com/article.asp?issn=0022-3859;year=1989;volume=35;issue=1;spage=3;epage=8;aulast=Doongaji;type=0


 
Sunday, March 29, 2020
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer